Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Enalapril × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2 Lymphoid 1

Conditions

Ventricular Dysfunction 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 10 pembrolizumab 9 Therapeutics 8 Radiotherapy 5 Gemcitabine 5 Flow Cytometry 5 Surveys and Questionnaires 4 Sirolimus 4 Psychiatric Rehabilitation 4 Peripheral Blood Stem Cell Transplantation 4 Paclitaxel 4 Methods 4 Ipilimumab 4 Exercise 4 Doxorubicin 4 Capecitabine 4 Blood Specimen Collection 4 aldesleukin 3 Rituximab 3 Nivolumab 3 Immunologic Techniques 3 Fluorodeoxyglucose F18 3 Filgrastim 3 Early Intervention, Educational 3 Drug Therapy 3 Carboplatin 3 Amplified Fragment Length Polymorphism Analysis 3 Albumin-Bound Paclitaxel 3 venetoclax 2 temsirolimus 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03265574 2024-02-20

PROACT

South Tees Hospitals NHS Foundation Trust

Phase 3 Completed

Breast Neoplasms, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡